Your browser doesn't support javascript.
loading
Benign Histiocyte-Rich Pseudotumor Developing Postchemotherapy and Mimicking Residual Disease.
Singh, Amrit P; Murray, Glenn P; Pandey, Soumya.
Affiliation
  • Singh AP; Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Murray GP; Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Pandey S; Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Case Rep Pathol ; 2020: 4674103, 2020.
Article in En | MEDLINE | ID: mdl-32695545
ABSTRACT
Histiocyte-rich pseudotumors (HRPT) developing postchemoradiation therapy are a florid response to treatment and reparative change. Although these are benign processes, clinically and radiologically, these may mimic recurrent/relapsed disease. We describe a case of an adult male with history of diffuse large B-cell lymphoma (DLBCL), status postchemoradiation therapy, who developed HRPT at the site of original involvement, mimicking relapse of disease on positron emission tomography/computed tomography (PET/CT) imaging. This is one of the few reported cases of posttreatment HRPT. This entity is important to point out the limitations of PET/CT imaging in patients with lymphomas and metastatic disease and stresses the importance of an excisional biopsy for determining relapse and the need for further treatment.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Case Rep Pathol Year: 2020 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Case Rep Pathol Year: 2020 Document type: Article Affiliation country: United States